CN104137981A - 一种蛹虫草海参片配方 - Google Patents
一种蛹虫草海参片配方 Download PDFInfo
- Publication number
- CN104137981A CN104137981A CN201310164547.0A CN201310164547A CN104137981A CN 104137981 A CN104137981 A CN 104137981A CN 201310164547 A CN201310164547 A CN 201310164547A CN 104137981 A CN104137981 A CN 104137981A
- Authority
- CN
- China
- Prior art keywords
- cordyceps militaris
- sea cucumber
- tablet
- extract
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241001264174 Cordyceps militaris Species 0.000 title claims abstract description 17
- 241000251511 Holothuroidea Species 0.000 title claims abstract description 17
- 239000007916 tablet composition Substances 0.000 title abstract 2
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 5
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 5
- 239000000843 powder Substances 0.000 claims abstract description 5
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims abstract description 4
- 239000007888 film coating Substances 0.000 claims abstract description 4
- 238000009501 film coating Methods 0.000 claims abstract description 4
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims abstract description 4
- 239000008108 microcrystalline cellulose Substances 0.000 claims abstract description 4
- 229940016286 microcrystalline cellulose Drugs 0.000 claims abstract description 4
- 239000011734 sodium Substances 0.000 claims abstract description 4
- 229910052708 sodium Inorganic materials 0.000 claims abstract description 4
- 241000234282 Allium Species 0.000 claims description 4
- 241000893536 Epimedium Species 0.000 claims description 4
- 235000015468 Lycium chinense Nutrition 0.000 claims description 4
- 235000013399 edible fruits Nutrition 0.000 claims description 4
- 235000018905 epimedium Nutrition 0.000 claims description 4
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims description 3
- UHZZMRAGKVHANO-UHFFFAOYSA-M chlormequat chloride Chemical compound [Cl-].C[N+](C)(C)CCCl UHZZMRAGKVHANO-UHFFFAOYSA-M 0.000 claims description 3
- 239000004148 curcumin Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 14
- 230000036039 immunity Effects 0.000 abstract description 9
- 230000036541 health Effects 0.000 abstract description 6
- 230000002708 enhancing effect Effects 0.000 abstract description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 abstract 2
- 235000018645 Allium odorum Nutrition 0.000 abstract 1
- 244000003377 Allium tuberosum Species 0.000 abstract 1
- 235000005338 Allium tuberosum Nutrition 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- 229920002472 Starch Polymers 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 235000020696 epimedium extract Nutrition 0.000 abstract 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 abstract 1
- 235000019359 magnesium stearate Nutrition 0.000 abstract 1
- 239000008107 starch Substances 0.000 abstract 1
- 235000019698 starch Nutrition 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 230000006870 function Effects 0.000 description 8
- 206010016256 fatigue Diseases 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 5
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 206010061598 Immunodeficiency Diseases 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 229930188089 Holothurin Natural products 0.000 description 1
- 241000725303 Human immunodeficiency virus Species 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000496 anti-anoxic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229940065181 bacillus anthracis Drugs 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000004097 bone metabolism Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- MAWWITJOQDJRJF-ADBICINLSA-M holothurin Chemical compound [Na+].O[C@@H]1[C@@H](OC)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O[C@H]3[C@@H](OC[C@H]([C@@H]3O)OS([O-])(=O)=O)O[C@@H]3C([C@H]4[C@](C=5[C@H]([C@@]6(CC[C@]7(O)[C@](C)([C@H]8OC(C)(C)CC8)OC(=O)[C@@]76[C@@H](O)C=5)C)CC4)(C)CC3)(C)C)O[C@@H]2C)O)O[C@H](C)[C@H]1O MAWWITJOQDJRJF-ADBICINLSA-M 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000001603 reducing effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
一种蛹虫草海参片配方，它涉及保健品领域。1000粒的蛹虫草海参片的重量配方比为淫羊藿提取物100～120g、韭菜籽提取物80～85g、蛹虫草子实体50～60g、枸杞提取物50～60g、海参冻干粉25～30g、微晶纤维素120～135g、羟甲基淀粉钠10～25g、薄膜包衣预混剂10～25g、硬脂酸镁2～6g。它的配方合理、成分明确、功效可靠、服用安全、无任何毒副作用；它采用片剂型，携带方便、便于保存；对免疫力低下者具有增强免疫力功能和对易疲劳者具有缓解体力疲劳功能。
Description
技术领域：
本发明涉及保健品领域，具体涉及一种蛹虫草海参片配方。
背景技术：
人体免疫功能是机体对外来异物的一种反应，机体可以识别自己和非己物质，并对非己物质加以排斥和清除，以维持体内环境平衡稳定的一种生理性防御反应，当人体的免疫功能很完善的时候疾病是不可能侵入身体的，疾病所到之处，其免疫抵抗力肯定虚弱。
随着生活节奏日益加快，且生活无规律，竞争的压力越来越大，许多人的免疫力较差，身体呈现亚健康状况，最有效的办法就是通过调节人体内部微环境来增强人体对疾病的免疫力提高免疫力多通过保健品来达到目的的。
但是目前市面上的滋补产品多为壮阳燥热药物，非长期病患者和体质虚弱者适用。
发明内容：
本发明的目的是提供一种蛹虫草海参片配方，它的配方合理、成分明确、功效可靠、服用安全、无任何毒副作用；它采用片剂型，携带方便、便于保存；它的加工技术先进、质量有保证，采用纯天然、无污染、不添加化学合的原料，对免疫力低下者具有增强免疫力功能和对易疲劳者具有缓解体力疲劳功能。
为了解决背景技术所存在的问题，本发明是采用以下技术方案：1000粒的蛹虫草海参片的重量配方比为淫羊藿提取物100～120g、韭菜籽提取物80～85g、蛹虫草子实体50～60g、枸杞提取物50～60g、海参冻干粉25～30g、微晶纤维素120～135g、羟甲基淀粉钠10～25g、薄膜包衣预混剂10～25g、硬脂酸镁2～6g。
本发明的配方合理、成分明确、功效可靠、服用安全、无任何毒副作用；它采用片剂型，携带方便、便于保存；它的加工技术先进、质量有保证，采用纯天然、无污染、不添加化学合的原料，对免疫力低下者具有增强免疫力功能和对易疲劳者具有缓解体力疲劳功能。
具体实施方式：
本具体实施采用以下技术方案：1000粒的蛹虫草海参片的重量配方比为淫羊藿提取物110g、韭菜籽提取物82.5g、蛹虫草子实体55g、枸杞提取物55g、海参冻干粉27.5g、微晶纤维素127.6g、羟甲基淀粉钠16.5g、薄膜包衣预混剂16.5g、硬脂酸镁4.4g。
所述的淫羊藿提取物具有抗癌作用，被喻为最有潜力的抗癌药物，它能增加心脑血管血流量、促进造血功能、免疫功能及骨代谢，具有补肾壮阳、抗衰老、抗肿瘤等功效
所述的韭菜籽提取物含生物碱和皂苷，能补肝肾、暖腰膝、兴阳道，治阳痿固精和妇人阴寒，小腹疼痛，是补肾壮腰的兴奋壮腰药，可用于治疗遗精、早泄、阳痿和多尿等症。
所述的蛹虫草子实体有较好的抗菌、抗病毒功能，对枯草杆菌、链球菌、炭疽杆菌等和一些致病性真菌有较好的抑制作用。对人体免疫缺陷性病毒HIVI型的侵染及其反转录酶的活性亦有抑制作用，。对体液免疫有调节作用，能增加脾脏重量，加速肝脏核酸和蛋白质更新速度；具有抗缺氧、增加心肌营养血流量及降低血清胆固醇和酯蛋白的作用，能提高肝脏解毒能力，起护肝作用，提高身体抗病毒和抗辐射能力。
所述的枸杞提取物具有抗氧化、抗衰老、抗肿瘤、降血脂、保肝、抗脂肪肝、降血糖等作用。
所述的海参冻干粉含丰富的氨基酸、有机化合物、海参素、矿物质、碳水化合物等成分，可促进机体细胞的再生和机体受损后的修复，还可提高人体的免疫力，拥有消除疲劳、延年益寿。
本具体实施的配方合理、成分明确、功效可靠、服用安全、无任何毒副作用；它采用片剂型，携带方便、便于保存；它的加工技术先进、质量有保证，采用纯天然、无污染、不添加化学合的原料，对免疫力低下者具有增强免疫力功能和对易疲劳者具有缓解体力疲劳功能。
Claims (1)
1.一种蛹虫草海参片配方，其特征在于1000粒的蛹虫草海参片的重量分配为淫羊藿提取物100～120g、韭菜籽提取物80～85g、蛹虫草子实体50～60g、枸杞提取物50～60g、海参冻干粉25～30g、微晶纤维素120～135g、羟甲基淀粉钠10～25g、薄膜包衣预混剂10～25g、硬脂酸镁2～6g。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310164547.0A CN104137981A (zh) | 2013-05-06 | 2013-05-06 | 一种蛹虫草海参片配方 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310164547.0A CN104137981A (zh) | 2013-05-06 | 2013-05-06 | 一种蛹虫草海参片配方 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104137981A true CN104137981A (zh) | 2014-11-12 |
Family
ID=51847464
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310164547.0A Pending CN104137981A (zh) | 2013-05-06 | 2013-05-06 | 一种蛹虫草海参片配方 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104137981A (zh) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104381996A (zh) * | 2014-11-19 | 2015-03-04 | 苏州俞氏药业有限公司 | 蛹虫草片及其制备方法 |
| CN105558896A (zh) * | 2016-01-05 | 2016-05-11 | 大连真久生物产业有限公司 | 含有海参及虫草为有效成分的组合物及其制备方法和应用 |
| CN107319396A (zh) * | 2017-08-09 | 2017-11-07 | 北京栋昱生物科技有限公司 | 一种参草滋补营养品及其制备方法 |
-
2013
- 2013-05-06 CN CN201310164547.0A patent/CN104137981A/zh active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104381996A (zh) * | 2014-11-19 | 2015-03-04 | 苏州俞氏药业有限公司 | 蛹虫草片及其制备方法 |
| CN105558896A (zh) * | 2016-01-05 | 2016-05-11 | 大连真久生物产业有限公司 | 含有海参及虫草为有效成分的组合物及其制备方法和应用 |
| CN107319396A (zh) * | 2017-08-09 | 2017-11-07 | 北京栋昱生物科技有限公司 | 一种参草滋补营养品及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106692906A (zh) | 消肿瘤的药物及其制备工艺 | |
| CN102552667B (zh) | 一种用于调节人体免疫力的中药组合物 | |
| CN101856384A (zh) | 一种护肝组合物 | |
| CN104137981A (zh) | 一种蛹虫草海参片配方 | |
| CN101884783A (zh) | 一种含有麦麸多肽的抗疲劳中药及其制备方法 | |
| CN105878899A (zh) | 一种对胃黏膜损伤有辅助治疗功能的食药及其制备方法 | |
| CN104997824A (zh) | 一种眼虫藻保健药、眼虫藻保健胶囊及其制备方法 | |
| CN110354236A (zh) | 一种治疗寒症的药物组合物及其制备方法 | |
| CN104666927B (zh) | 一种中药组合物及其调节人体免疫功能和/或抗肿瘤应用 | |
| CN103610923A (zh) | 一种提高人体免疫力的药物 | |
| CN104286832B (zh) | 一种具有增强免疫力、祛黄褐斑功效的保健品及其制备方法 | |
| CN101869329B (zh) | 延年益寿防癌保健饮料 | |
| CN101797280B (zh) | 一种防衰老的中药制剂 | |
| CN105494749A (zh) | 一种益气健脾抗癌保健茶包及其制备方法 | |
| CN101991037B (zh) | 当归不老莓丸及其制作方法 | |
| CN106039258A (zh) | 用于增强免疫力的组合物及其应用 | |
| CN104815134A (zh) | 一种对生理有多功能作用的中药复方制剂及其应用 | |
| CN104041822A (zh) | 具有保健效果的组合物及其制备方法 | |
| CN101972355A (zh) | 一种综合补肾的中药 | |
| CN103142751A (zh) | 治疗仔猪缺铁性贫血的中药组合物 | |
| CN105853564A (zh) | 一种针对阳虚体质的保健品及其制备方法 | |
| CN106723022A (zh) | 一种梅花鹿茸蝙蝠蛾拟青霉菌胶囊及其制备方法 | |
| CN104983955A (zh) | 一种减肥美容的药物 | |
| CN104998199A (zh) | 治疗多种癌症的组合物 | |
| CN105341563A (zh) | 一种益智健脑食疗养生粉配方 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20141112 |